These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 28947112

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dystonia-predominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults.
    Louis ED, Anderson KE, Moskowitz C, Thorne DZ, Marder K.
    Arch Neurol; 2000 Sep; 57(9):1326-30. PubMed ID: 10987900
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Involuntary movement disorders.
    Still CN.
    Neurol Clin; 1984 Feb; 2(1):71-89. PubMed ID: 6239089
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An MDS Evidence-Based Review on Treatments for Huntington's Disease.
    Ferreira JJ, Rodrigues FB, Duarte GS, Mestre TA, Bachoud-Levi AC, Bentivoglio AR, Burgunder JM, Cardoso F, Claassen DO, Landwehrmeyer GB, Kulisevsky J, Nirenberg MJ, Rosser A, Roth J, Seppi K, Slawek J, Furr-Stimming E, Tabrizi SJ, Walker FO, Vandenberghe W, Costa J, Sampaio C.
    Mov Disord; 2022 Jan; 37(1):25-35. PubMed ID: 34842303
    [Abstract] [Full Text] [Related]

  • 13. Dopamine depleters in the treatment of hyperkinetic movement disorders.
    Jankovic J.
    Expert Opin Pharmacother; 2016 Dec; 17(18):2461-2470. PubMed ID: 27819145
    [Abstract] [Full Text] [Related]

  • 14. Current Pharmacological Approaches to Reduce Chorea in Huntington's Disease.
    Coppen EM, Roos RA.
    Drugs; 2017 Jan; 77(1):29-46. PubMed ID: 27988871
    [Abstract] [Full Text] [Related]

  • 15. Therapeutics of disordered movement.
    Sears ES.
    Am Fam Physician; 1977 Sep; 16(3):145-54. PubMed ID: 143204
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An experimental model for Huntington's chorea?
    Zeef DH, Jahanshahi A, Vlamings R, Casaca-Carreira J, Santegoeds RG, Janssen ML, Oosterloo M, Temel Y.
    Behav Brain Res; 2014 Apr 01; 262():31-4. PubMed ID: 24412685
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.